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Prevalence and correlates of frailty in an
older rural African population: findings
from the HAALSI cohort study
Collin F. Payne1, Alisha Wade2, Chodziwadziwa W. Kabudula2, Justine I. Davies2,3, Angela Y. Chang4,
F. Xavier Gomez-Olive1,2, Kathleen Kahn2,5,8, Lisa F. Berkman1,2, Stephen M. Tollman2,5,8, Joshua A. Salomon6
and Miles D. Witham2,7*
Abstract
Background: Frailty is a key predictor of death and dependency, yet little is known about frailty in sub-Saharan
Africa despite rapid population ageing. We describe the prevalence and correlates of phenotypic frailty using data
from the Health and Aging in Africa: Longitudinal Studies of an INDEPTH Community cohort.
Methods: We analysed data from rural South Africans aged 40 and over. We used low grip strength, slow gait
speed, low body mass index, and combinations of self-reported exhaustion, decline in health, low physical activity
and high self-reported sedentariness to derive nine variants of a phenotypic frailty score. Each frailty category was
compared with self-reported health, subjective wellbeing, impairment in activities of daily living and the presence
of multimorbidity. Cox regression analyses were used to compare subsequent all-cause mortality for non-frail
(score 0), pre-frail (score 1–2) and frail participants (score 3+).
Results: Five thousand fifty nine individuals (mean age 61.7 years, 2714 female) were included in the analyses. The
nine frailty score variants yielded a range of frailty prevalences (5.4% to 13.2%). For all variants, rates were higher in
women than in men, and rose steeply with age. Frailty was associated with worse subjective wellbeing, and worse self-
reported health. Both prefrailty and frailty were associated with a higher risk of death during a mean 17 month follow
up for all score variants (hazard ratios 1.29 to 2.41 for pre-frail vs non-frail; hazard ratios 2.65 to 8.91 for frail vs non-frail).
Conclusions: Phenotypic frailty could be measured in this older South African population, and was associated with
worse health, wellbeing and earlier death.
Keywords: Fried frailty score, Mortality, Multimorbidity, Activities of daily living, Rural South Africa
Background
Frailty, conceptualised as the loss of ability to withstand
a stressor [1], has emerged as a key construct in ageing
and geriatric medicine over the last 15 years. In high-
income countries, frailty has been shown to be an inde-
pendent predictor of mortality, falls, length of hospital
stay, functional decline, and need for social care [2–5].
Frailty also identifies the group of older people in
higher-income countries most likely to benefit from
Comprehensive Geriatric Assessment – a major health-
care intervention shown to improve outcomes in older
people [6]. Frailty indices therefore have the potential to
assist with identification of those at highest risk of these
adverse outcomes, and hence target interventions to
those most likely to benefit. Population-based studies on
frailty can aid in identifying people at risk of frailty and
the development of strategies for altering the trajectory
towards frailty. As population ageing reaches across the
world, preventive strategies to limit frailty and maximize
healthy life expectancy will become increasingly important.
There are two main methods of identifying frailty –
phenotypic scores and cumulative deficit scores. Phenotypic
scores (e.g. the Fried frailty criteria [1]) focus on physical
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frailty and use a small number of measures – in Fried’s
original paper, these were slow walk speed, low muscle
strength, weight loss, self-reported exhaustion and
self-reported low activity levels. In contrast, cumula-
tive deficit models (e.g. Rockwood’s frailty index [7])
work by tallying the number of deficits across a wide
range of organ systems – for instance diagnoses of
disease, but also deficits on biochemical testing, cog-
nitive test scores, and low measures of physiological
function such as lung function or muscle strength.
Such an approach is usually thought to require at
least 30 variables for a reliable score [8].
Almost all work on frailty has taken place in older
populations in high-income countries, characterised by
well-funded, well-staffed, easily accessible healthcare
services. Some work has been done in lower and
middle-income countries, but this has mostly been con-
fined to China, Mexico and Brazil [9]. The prevalence of
frailty is very variable, both between countries, but also
between populations within countries. A recent meta-
analysis of Japanese studies showed a frailty rate of 7.4%
in those aged 65 and over [10]. The prevalence in
community-dwelling people in Europe and the USA was
noted to be 10% in another recent analysis [11], but was
higher in Latin America at nearly 20% [12]. A recent
analysis using the frailty index approach suggested a
lower prevalence of frailty amongst LMICs (Russia,
China, South Africa, India, Ghana and Mexico) than in
European countries [13]. This difference may be driven
by methodological differences, but may also be due to
survivor bias - in European countries, high quality health
and social care systems may support those with frailty to
live longer. A review of studies in LMICs, including
Brazil, Mexico, China and Russia, suggested high rates
of phenotypic frailty in community-dwelling older
adults, from 17 to 44% depending on definition and
population [14]. Given this disparity in prevalence rates
between methods, settings and countries, data are re-
quired that are country-specific, using tools validated
within the country or region of interest.
Populations in South Africa are now ageing at a rapid
rate as a result of the scale-up of anti-HIV therapies
[15]. There is consequently an urgent need to ensure
that widely used frailty tools – which were developed
elsewhere - are appropriate for use in a local population
in order to inform the development of health and social
care interventions and service delivery to maintain
health and function in older age. Cumulative deficit
frailty scores require collection of data on a large num-
ber of health domains – data that are not readily avail-
able in many healthcare systems in lower and middle
income countries. In contrast, phenotypic frailty lends it-
self to measurement in both clinical and research prac-
tice even in resource-poor environments, as it does not
require comprehensive sets of diagnoses or laboratory
tests. In this paper, our objectives were to ascertain the
prevalence of phenotypic frailty in a rural South African
population of older people using a range of different
ways of constructing a frailty phenotype score, to test
whether phenotypic frailty was a distinct construct from
disability and multimorbidity in this population, and to
test whether frailty associated with earlier death and
worse health and wellbeing in this population. We
hypothesised that prevalence rates would differ from
those seen in high income countries as a result of the
above issues, that prevalence rates would vary depending
on the ingredients of the frailty score, and that those
individuals identified as being frail would have higher
mortality rates, higher rates of impairment of Activities
of Daily Living, and lower quality of life and general
health than those who were non-frail. We also hypothe-
sised that the group who were frail would be distinct
from, but overlap with, those with disability and with
multimorbidity.
Methods
We used data from the Health and Aging in Africa:
Longitudinal Studies of an INDEPTH community
(HAALSI) survey of older people, conducted in the
Agincourt subdistrict of rural northeast South Africa. As
described previously [16], inclusion criteria for selection
in the sampling frame were based on being permanently
resident in the Agincourt HDSS area during the
12 months prior to the 2013 Agincourt Health and
socio-Demographic Survey System (HDSS) census round
[17], and aged 40 or over on July 1st 2014. Applying
these criteria to the full 2013 Census data, produced a
sampling frame of 8974 women and 3901 men aged 40
and older who met the residence criteria. Based on the
assumption of an 80% response rate, we approached a
total of 6281 people. Men were oversampled to ensure
approximately even gender balance in the final con-
sented sample. 5059 (85.9%) consented to participate in
the HAALSI survey and provide the data for analysis in
this paper. Participants unwilling or unable to consent
to participate were excluded. Ethics committee approvals
for HAALSI were obtained from the University of the
Witwatersrand Human Research Ethics Committee
(#M141159), the Harvard T.H. Chan School of Public
Health Office of Human Research Administration (#13–
1608), and the Mpumalanga Provincial Research and
Ethics Committee.
All main survey data were collected in participants
own place of residence. Data were collected by trained,
local fieldworkers on laptops using Computer Assisted
Personal Interviews (CAPI). Surveys were conducted in
the local Shangaan language, with instruments translated
from English and back-translated to ensure reliability.
Payne et al. BMC Geriatrics  (2017) 17:293 Page 2 of 10
Measures of physical performance, blood tests and blood
pressure were also conducted by the same fieldworkers,
in the participant’s place of residence.
Frailty score components
To measure walking speed, participants were asked to
walk a 2.5 m course twice, with the time taken timed to
the nearest 0.1 s. The course was marked out on flat,
obstacle-free ground in or around the participant’s
home. Participants were allowed to use any usual walk-
ing aids but no human assistance was permitted; partici-
pants started the course from a stationary standing
position. The second walk was conducted on a course
that was the reverse of the first course. Participants un-
able to conduct the walk test were assigned a walk speed
of 0 m/s; those who declined to participate were omitted
from analysis. The time for both walks was summed and
a mean walk speed derived.
Grip strength was measured twice in both hands,
using a Smedley digital dynamometer (12–0286). Testing
was conducted with participants in a seated position,
with the arm being tested held at 90 degrees of elbow
flexion. For this analysis, the maximum reading achieved
in either hand was used, as is the case in the majority of
published cohorts [18]. Participants who were unable to
perform grip strength testing because of pain or deform-
ity in both hands, or other physical disability, were
assigned a grip strength of 0 kg; no participant declined
to participate in grip strength testing. Although no sep-
arate record was taken of those unable to complete grip
testing due to cognitive impairment, most participants
with missing grip strength data were able to complete
other parts of the survey including cognitive testing,
suggesting that cognition alone was unlikely to have pre-
vented completion of grip strength testing.
Body mass index was derived from height measured to
the nearest centimetre using an infra-red height sensor,
and weight measured to the nearest 0.1 kg using the
Genesis Growth Management Electronic Scale (Genesis;
Johannesburg, South Africa). Physical activity was mea-
sured by self-report using the Global Physical Activity
Questionnaire (GPAQ) [19]. Responses were used to cal-
culate weekly activity in metabolic equivalents (METS).
Sedentary time in hours per week was calculated from
questionnaire responses; questions asked “how many
hours did you spend sitting or reclining (excluding sleep)
each weekday / weekend day”.
Self-reported exhaustion was measured using a positive
response to a single question from the CES-D depression
screening questionnaire: ‘much of the time you could not
get going’ [20]. The original derivation of a frailty score by
Fried et al. [1] used a positive response to either this
question or a second question (‘everything you did was an
effort’). Results from this second question could not be
used due to ambiguities in the translation to the local
Shangaan language. As an alternative to asking about ex-
haustion, we asked about change in overall health using
the question ‘how has your overall health changed in the
last 12 months’, with an answer of ‘worse’ or ‘much worse’
on a 5 point scale denoting a positive response. Whist this
criterion differs from the original Fried criteria, the
use of a question denoting decline over time is con-
sistent with the vicious cycle of decline posited by
Fried et al. as an underlying conceptual model for
their frailty score.
Grip strength and walk speed were additionally
adjusted for height as part of some frailty score variants.
Regression analyses were run for males and females sep-
arately to calculate how grip and walk speed changed
per cm increase in height. Both were normalised to the
mean height (168 cm for men and 158 cm for women)
of the HAALSI population; values of 0.29 kg per cm
height (men) and 0.27 kg per cm height (women) were
used to adjust grip strength; for walk speed, values of
0.0284 m/s (men) and 0.0392 m/s (women) were used.
Calculation of frailty scores
We derived nine variants of a frailty score. Differences
in available data between the original Fried derivation of
frailty and the data available in HAALSI drove the
choice of some components, but we also selected
variants to explore the effect of height adjustment vs no
height adjustment, and use of externally-derived thresh-
olds vs use of lowest quintiles. Components of each
score are depicted in the Additional file 1: Table S1. For
each variant, we derived frailty classification in two ways:
firstly, we included participants if at least three compo-
nents were positive for frailty (frail) or three components
were negative for frailty (non-frail). This allowed classifi-
cation as non-frail or frail even if one or two compo-
nents were missing in some cases. As this method did
not allow classification as ‘pre-frail’ (1 or 2 components
positive for frailty), we also derived classifications using
only those participants with data on all components for
a particular frailty score variant. We classified partici-
pants as non-frail (score 0); pre-frail (score 1 or 2) or
frail (score 3 or more) for each frailty score as per Fried’s
original derivation [1]. No weighting was applied to the
components and no imputation was attempted for miss-
ing variables.
For some frailty score components, we selected external
cutpoints based on previously published data. For low
weight we used BMI < 18.5 kg/m2, a value widely used
to define underweight [21]. For walk speed, we used
<0.8 m/s, consistent with the value used to define sarcope-
nia in the European Sarcopenia Working group definition
[22]. Male and female grip cutoffs are based on the 25th
centile of grip found in healthy African populations aged
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35–50 [23]. Additional file 1: Table S1 summarises the
components of frailty scores that we considered, and the
combinations of components that constituted the nine
frailty score variants that we tested.
Association with other constructs
To ascertain the utility of the scores in the local popula-
tion, we tested the association between each frailty score
and outcomes known to be associated with frailty, and
also with variables measuring related but distinct
constructs. Subjective wellbeing, self-reported health,
impairment of basic activities of daily living (ADLs), and
the presence of multimorbidity were assessed; methods
for assessment are detailed in the Additional file 2. Date
of death of individuals was ascertained during the 2016
HDSS census round (conducted between August and
December 2016) by report from household members as
previously described [17].
Analyses
We analysed characteristics of the HAALSI popula-
tion, prevalence of individual frailty components, and
prevalence of frailty score categories for each frailty
score variant. Overlaps between multimorbidity, dis-
ability (at least one impairment of basic ADLs) and
frailty (score 3 or more) were depicted graphically.
Wellbeing and general health were compared across
frailty categories using ANOVA; the proportion of
participants with at least 1 ADL impairment was
compared across frailty categories using Pearson’s
Chi-squared test.
Prediction of death by frailty category was performed
using Cox regression, both unadjusted and adjusted for
age and sex. Time to death from the date of first
HAALSI interview was the dependent variable, and
frailty category (non-frail, pre-frail, frail) for each frailty
score was the predictor variable. Follow up was censored
at the date which the individual was interviewed in the
next HDSS census round, or the date of migration out
of the Agincourt sub-district. A two-sided p value of
<0.05 denoted significance for all analyses. Analyses
were conducted using SPSS v24 (IBM, New York, USA).
Results
A total of 5059 participants were recruited in HAALSI;
baseline details for the HAALSI cohort are given in
Table 1. Additional file 1: Table S2 shows the prevalence
of each component in the HAALSI population, together
with missing data rates. Missing data rates were low
(<5%) for all components except BMI, number of seden-
tary hours per week, and height-adjusted grip and walk
speed measures.
Table 2 shows the prevalence of frailty and pre-frailty
for each of the score variants. The prevalence of frailty
was similar for most frailty score variants, but was mark-
edly higher for those variants (6 and 7) using an
unadjusted walk speed cutpoint of 0.8 m/s. Similarly, the
prevalence of prefrailty was much higher, and the preva-
lence of non-frailty much lower, when using these two
frailty score variants; the same finding was evident for
the score variant (variant 9) using height-adjusted grip
and walkspeed with externally derived cutpoints. Rates of
non-calculable scores were unsurprisingly higher for all
score variants when all five components were required to
be present. Figure 1 shows that as expected, the preva-
lence of frailty rises with increasing age for both men and
women, particularly over the age of 70 years.
Table 3 shows the prevalence of disability (at least 1
ADL impairment), self-reported general health scores,
and self-reported satisfaction scores across different
levels of frailty for each score variant as a test of the
construct validity of the frailty scores. For each score
variant, participants in the frail category had worse out-
comes in these domains than those in the non-frail cat-
egory. A similar pattern was seen for scores calculated
from all 5 components (Additional file 1: Table S3),
where a clear gradient was evident from non-frail, to
pre-frail and frail for each score variant. Individuals for
whom a score could not be calculated had worse quality
of life, worse general health and more ADL impairment
than non-frail individuals. For score variants with
more missing data, including scores calculated from
all 5 components, ADL impairment rates were much
higher in those with non-calculable scores than in
those who were frail.
There were 241 deaths during a mean follow up period
of 17 months. Table 4 shows the results of Cox regres-
sion analyses comparing the hazard ratio for death
during follow up for frailty strata in the different score
variants; Additional file 1: Table S4 shows the same
results using score variants calculated in those with all 5
components present. In unadjusted analyses, a clear gra-
dient of risk of death was seen for all scores between
non-frail, pre-frail and frail; the gradient was attenuated
after adjustment for age, sex, comorbid disease, cogni-
tion, marital status and socioeconomic status, Whilst
frailty category remained a strong predictor of death in
each frailty score variant, some differences were evident
between scores; score variants using a walk speed cut-
point of <0.8 m/s or those adjusting for height (variants
6,7,8 and 9) showed less difference in the risk of death
between frail and non-frail individuals after adjustment
for covariates. Score variants with more missing data
tended to show lower hazard ratios for frailty, but higher
hazard ratios for those for whom a frailty category could
not be assigned.
C-statistics using death during the 12 months following
baseline assessment as the dependent variable were similar
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for each frailty score variant, with slightly higher c-
statistics for score variants incorporating height adjust-
ment. The combination of frailty score, demographic vari-
ables and comorbidity had high discriminatory value, with
c-statistics between 0.80 and 0.85 for the different score
variants as shown in Additional file 1: Table S5.
The Additional file 3: Figure S1 demonstrates the par-
tial overlap between frailty, multimorbidity and disability
for frailty score variant 1. Few participants were multi-
morbid, frail, and had ADL impairment, and only partial
overlap was seen between frailty and ADL impairment
despite relatively low numbers in both categories. Pat-
terns of overlap were similar for all frailty score variants.
Discussion
We have shown that variations of a phenotypic frailty
score can be derived in this population of older rural
South Africans, that these frailty score variants correlate
with ADL impairment, poor self-reported general health
and wellbeing, and that they independently predict all-
cause mortality even after adjustment for comorbidity,
cognition, demographic measures and socioeconomic
measures. These results suggest that the frailty scores we
derive measure a distinct construct to simply age or
comorbid disease, and that they correlate with related
constructs – a key component of validity. Although the
precise measures in the scores that we derived differ
slightly from the original criteria used by Fried et al.,
they were chosen to capture similar aspects to the
underlying concept – a vicious cycle of decline – on
which Fried and colleagues predicated their original
frailty score. Each variant performed similarly; clear gra-
dients of worsening self-reported health and subjective
wellbeing with increasing frailty category were evident,
rates of frailty were higher in women than in men at any
given age as found previously [1], and rates of frailty rose
steeply with age as expected. Furthermore, both frailty
and pre-frailty predicted time to death over a mean
17 month follow-up, and ADL impairments were more
common amongst the frail as compared to both pre-frail
and non-frail. Importantly, although there was overlap
between those with multimorbidity, frailty and disability,
there was by no means complete congruence between
these measurements. Current paradigms suggest that
multimorbidity is a precursor to the development of
frailty, and that frailty is a precursor to the development
Table 1 Baseline details of the HAALSI cohort (n = 5059)
Female Male All P*
N (%) 2714 (53.6) 2345 (46.4) 5059 –
Mean age (years) (SD) 61.7 (13.3) 61.7 (12.8) 61.7 (13.1) 0.95
Age group (%) 40–49 500 (18) 418 (18) 918 (18) <0.001
50–59 785 (29) 625 (27) 1410 (28)
60–69 661 (24) 643 (27) 1304 (26)
70–79 432 (16) 446 (19) 878 (17)
80+ 336 (12) 213 (9) 549 (11)
Marital status Never married 123 (5) 166 (7) 289 (6) <0.001
Divorced/separated 351 (13) 299 (13) 650 (13)
Widowed 1264 (47) 277 (12) 1541 (30)
Married/cohabiting 973 (36) 1601 (68) 2574 (51)
HIV positive (%) 565 (21) 482 (23) 1047 (21) 0.82
Previous angina (%) 293 (11) 163 (7) 456 (9) <0.001
Previous stroke (%) 63 (3) 86 (3) 149 (3) 0.31
Hypertension (%) 1806 (67) 1338 (57) 3145 (62) <0.001
Diabetes mellitus (%) 324 (12) 235 (10) 559 (11) 0.03
Chronic bronchitis (%) 12 (0.4) 16 (0.7) 28 (0.6) 0.25
Anaemia (%) 1042 (38) 833 (36) 1875 (37) 0.15
Median 5 m walk speed (m/s) (IQR) 0.63 (0.50 to 0.83) 0.63 (0.50 to 0.83) 0.63 (0.50 to 0.83) <0.001
Median maximum grip strength (Kg) (IQR) 22.5(17.7 to 27.3) 30.7 (23.2 to 37.2) 25.4 (19.3 to 32.3) <0.001
Mean body mass index (Kg/m2) (SD) 29.3 (7.5) 24.9 (5.4) 27.3 (7.0) <0.001
> = 1 basic ADL impairment (%) 257/2709 (9.5) 219/2332 (9.4) 476/5042 (9.4) 0.90
ADL Activity of daily living
*p for male vs female
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of disability [10]. Causal progression through these con-
cepts is not inevitable however, with other factors (e.g.
occult disease) contributing to frailty, and alternative
pathways (e.g. a specific deficit such as a stroke) may
lead to disability. Overlap between these concepts should
therefore be incomplete, and our results support the fact
that our frailty scores measure a concept distinct from
both multimorbidity and disability. Our results suggest
that the frailty construct that we are measuring behaves
similarly to phenotypic frailty as measured in high
income countries [1, 11], and that the ability of frailty to
predict death in high-income countries also applies to
older populations in this rural South African setting.
Our choice of frailty score components was necessi-
tated in part by the measures included in the HAALSI
survey, but also in part by logistical and cultural con-
straints. Quantifying weight loss for instance, was not
possible as most older South Africans do not keep
records of previous weight for comparison. Some ques-
tions for self-report (e.g. ‘everything is an effort’) did not
translate easily to a similar concept in the population
studied in this work and thus do not provide reliable
data. Each population has characteristics of genetics,
health behaviors, healthcare, comorbidity and ageing
that are intimately linked to the particular countries and
regions studied. It cannot therefore be assumed that
existing frailty scores will automatically translate to low
or middle income countries in other global regions, for
instance sub-Saharan Africa. Furthermore, changes to
the components included in phenotypic frailty scores
can have significant impacts on the prevalence of frailty
within a given population [11], thus any variation in how
a frailty score is operationalised requires evaluation.
Nevertheless, by choosing variables similar to those used
by Fried et al., we aimed to preserve the concepts used
by other phenotypic frailty scores even though the spe-
cific variables may differ slightly. The results from our
analyses reinforce the need to derive appropriate thresh-
olds for frailty score components in different popula-
tions; the very high prevalence of walk speed <0.8 m/s
led to most of the study population being characterised
as pre-frail; such an approach did not improve the
strength of association between frailty scores and other
outcomes. Similarly, a cutoff of <18.5 kg/m2 for BMI
may not be appropriate for this population, and impos-
ition of external cutpoints is a departure from the
approach used by Fried et al. Use of a grip strength
threshold derived from previous work in African popula-
tions was more successful, although such an approach
was not superior to a quintile-based approach. Adjusting
walk speed and grip for height weakened most associa-
tions studied; such an approach cannot therefore be
recommended for this population as it adds to the com-
plexity of measurement without adding to the usefulness
of the frailty scores. As measured physical performance
(grip strength, gait speed) in the HAALSI cohort was
Table 2 Prevalence of each category of frailty for all frailty score variants in HAALSI (n = 5059)
Frailty score
variant
Allowing some missing data Including only those with data on all 5 components
<3 (non-frail) (%) 3+ (frail) (%) Not calculable (%) 0 (non-frail) (%) 1–2 (pre-frail) (%) 3+ (frail) (%) Not calculable (%)
1 4477 (88.4) 372 (7.4) 210 (4.2) 2169 (42.9) 2117 (41.8) 228 (4.5) 545 (10.8)
2 4457 (88.1) 413 (8.2) 189 (3.7) 1949 (38.5) 2339 (46.1) 277 (5.5) 494 (9.8)
3 4486 (88.7) 337 (6.7) 236 (4.7) 1781 (35.2) 2308 (45.6) 238 (4.7) 732 (14.5)
4 4466 (88.3) 362 (7.2) 231 (4.6) 2097 (41.5) 2187 (43.2) 230 (4.5) 545 (10.8)
5 4561 (90.2) 288 (5.7) 210 (4.2) 2540 (50.2) 1822 (36.0) 153 (3.0) 544 (10.8)
6 4225 (83.5) 670 (13.2) 164 (3.2) 824 (16.3) 3304 (65.3) 487 (9.6) 444 (8.8)
7 4337 (85.7) 545 (10.8) 177 (3.5) 932 (18.4) 3312 (65.5) 372 (7.4) 443 (8.8)
8 4381 (86.6) 290 (5.7) 388 (7.7) 2018 (39.9) 2324 (45.9) 273 (5.4) 444 (8.8)
9 4322 (85.4) 337 (6.7) 400 (7.9) 888 (17.6) 3409 (67.4) 315 (6.2) 447 (8.8)
Fig. 1 Differences in prevalence of frailty by sex and age category in
HAALSI (frailty score variant 1)
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low by international comparison [12], the thresholds for
deriving frailty components by quintiles in our study
were very different from those used in high-income
countries, reinforcing the need to use population-
specific thresholds when operationalising frailty scores.
The similar performance seen for all the variants on a
frailty score that we tested suggests that this is a robust
approach to take, that the construct is able to tolerate
multiple variations in its component parts, and that the
construct measured by phenotypic frailty performs in
South Africa in a similar way to in high-income coun-
tries (HICs). Our missing data rates for individual com-
ponents of the frailty scores were low (0 to 7% of
measures studied), and most people in the study popula-
tion could be assigned a frailty category. The prevalence
of frailty seen in this population was similar to that seen
in some previous population-level studies; this is perhaps
unsurprising given that for many of the components, the
bottom 20% of the distribution was used to derive frailty,
but similar prevalence figures were seen even when im-
posing externally derived cutpoints. Missing data may
have led to an underestimate of the prevalence of frailty,
as those with multiple missing datapoints are perhaps
more likely to the frailest. This is borne out by the high
hazard ratios for death, the high rates of ADL impair-
ment and poor self-reported health in those for whom a
frailty score could not be calculated. Inability to calcu-
late a frailty score should therefore act as a marker for
poor outcomes in the same way as frailty itself. Studies
from other countries have shown a wide range of frailty
prevalence, dependent on the age of those studied, as
well as the group under study; those under medical care
Table 3 Association between frailty score variants, wellbeing, self-reported health, and ADL impairment in HAALSI. Allowing some
missing data
Frailty score variant > = 1 ADL impairment (%) Mean self-reported
health score (SD)
Mean subjective
wellbeing score (SD)
1 Non-frail 232/4466 (5.2) 2.22 (0.98) 6.87 (2.34)
Frail 177/370* (47.8) 3.33* (1.14) 5.24* (2.49)
Unable to calculate 67/206* (32.5) 2.81* (1.18) 5.93* (2.59)
2 Non-frail 241/4444 (5.4) 2.23 (0.98) 6.86 (2.35)
Frail 180/410* (43.9) 3.25* (1.18) 5.49* (2.55)
Unable to calculate 55/188* (29.3) 2.69* (1.14) 6.09* (2.66)
3 Non-frail 276/4473 (6.2) 2.24 (0.98) 6.85 (2.33)
Frail 114/334* (34.1) 3.14* (1.23) 5.62* (2.77)
Unable to calculate 86/235* (36.6) 2.87* (1.18) 5.90* (2.70)
4 Non-frail 228/4456 (5.1) 2.22 (0.98) 6.87 (2.34)
Frail 170/359* (47.4) 3.27* (1.16) 5.25* (2.52)
Unable to calculate 78/227* (34.4) 2.87* (1.19) 5.93* (2.62)
5 Non-frail 248/4549 (5.5) 2.23 (0.98) 6.85 (2.35)
Frail 161/287* (56.1) 3.42* (1.14) 5.17* (2.56)
Unable to calculate 67/206* (32.5) 2.87* (1.19) 5.91* (2.62)
6 Non-frail 207/4215 (4.9) 2.20 (0.97) 6.94 (2.32)
Frail 223/665* (33.5) 3.04* (1.16) 5.36* (2.41)
Unable to calculate 46/162* (28.4) 2.73* (1.13) 6.27* (2.62)
7 Non-frail 223/4328 (5.2) 2.22 (0.98) 6.90 (2.35)
Frail 201/540* (37.2) 3.06* (1.17) 5.45* (2.40)
Unable to calculate 52/174* (29.9) 2.82* (1.15) 6.15* (2.63)
8 Non-frail 239/4372 (5.5) 2.24 (0.99) 6.86 (2.35)
Frail 70/286* (24.5) 2.83* (1.11) 5.78* (2.34)
Unable to calculate 167/384* (43.5) 2.95* (1.27) 5.86* (2.72)
9 Non-frail 228/4313 (5.3) 2.23 (0.98) 6.88 (2.35)
Frail 82/333* (24.6) 2.90* (1.08) 5.75* (2.37)
Unable to calculate 166/396* (41.9) 2.92* (1.25) 5.86* (2.70)
ADL Activity of Daily Living
*p < 0.05 vs non-frail
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or in institutional care have much higher rates of frailty
than those from general community-dwelling older pop-
ulations. A recent meta-analysis of Japanese studies
showed a frailty rate of 7.4% in those aged 65 and over
[13]. Prevalence in community-dwelling people in
Europe and the USA was noted to be 10% in another
recent analysis [14], but was higher in Latin America at
nearly 20% [24].
Comparing the prevalence of frailty between countries
is thus fraught with difficulty. A recent analysis using the
frailty index approach suggested a lower prevalence of
frailty amongst LMICs (Russia, China, South Africa, India,
Ghana and Mexico) than in European countries [25]. This
difference may be driven by methodological differences,
but may also (particularly for frailty index approaches) be
due to less comprehensive diagnoses. If characterisation of
frailty requires measurement and diagnosis across many
body systems, failure to investigate and make diagnoses
will tend to underestimate the prevalence of frailty. An-
other possible explanation is survivor bias - in European
countries, high quality health and social care systems may
support those with frailty to live longer. A review of stud-
ies in LMICs, including Brazil, Mexico, China and Russia,
suggested high rates of phenotypic frailty in community-
dwelling older adults, from 17 to 44% depending on defin-
ition and population [26]. It is important to note that the
HAALSI population are younger (aged 40 and above) than
those studied in the majority of HICs; the age-specific
frailty prevalence within HAALSI is therefore higher than
that seen in most previous studies in HICs, but is
somewhat more similar to that seen in Latin America.
This premature onset of frailty within LMIC populations
is likely to pose important challenges for health and long-
term care systems in LMICs.
Table 4 Hazard ratios for time to death for frailty categories in HAALSI. Allowing some missing data
Frailty score variant Unadjusted
hazard ratio (95% CI)
Adjusted
hazard ratio (95% CI)
1 Non-frail 1 (−) 1 (−)
Frail 7.66 (5.80 to 10.12) 4.12 (2.89 to 5.87)
Unable to calculate 5.08 (3.38 to 7.63) 3.20 (1.89 to 5.40)
2 Non-frail 1 (−) 1 (−)
Frail 7.20 (5.47 to 9.47) 3.85 (2.73 to 5.44)
Unable to calculate 4.73 (3.06 to 7.30) 2.96 (1.73 to 5.07)
3 Non-frail 1 (−) 1 (−)
Frail 6.21 (4.59 to 8.41) 3.48 (2.39 to 5.07)
Unable to calculate 6.96 (4.96 to 9.77) 4.38 (2.89 to 6.65)
4 Non-frail 1 (−) 1 (−)
Frail 8.28 (6.27 to 10.95) 4.15 (2.94 to 5.86)
Unable to calculate 5.30 (3.59 to 7.84) 2.74 (1.64 to 4.57)
5 Non-frail 1 (−) 1 (−)
Frail 8.91 (6.70 to 11.85) 4.63 (3.22 to 6.68)
Unable to calculate 5.19 (3.48 to 7.73) 3.22 (1.91 to 5.44)
6 Non-frail 1 (−) 1 (−)
Frail 5.62 (4.32 to 7.32) 3.15 (2.28 to 4.35)
Unable to calculate 3.95 (2.38 to 6.55) 2.30 (1.20 to 4.44)
7 Non-frail 1 (−) 1 (−)
Frail 6.13 (4.69 to 8.02) 2.68 (1.92 to 3.74)
Unable to calculate 4.42 (2.79 to 7.00) 2.31 (1.26 to 4.23)
8 Non-frail 1 (−) 1 (−)
Frail 2.78 (1.79 to 4.34) 1.78 (1.09 to 2.89)
Unable to calculate 9.58 (7.31 to 12.55) 5.93 (4.36 to 8.26)
9 Non-frail 1 (−) 1 (−)
Frail 2.65 (1.73 to 4.07) 1.45 (0.91 to 2.32)
Unable to calculate 9.43 (7.19 to 12.36) 5.67 (4.06 to 7.91)
Adjusted for age, sex, hypertension, diabetes, stroke, chronic lung disease, anaemia, HIV, cognitive score, married/cohabiting vs single, and quintile of household
wealth index
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Our study has a number of strengths. We used a large
population-based sample; our results are therefore likely
to be generalisable to a range of older South Africans
living in rural environments. Our missing data rate was
low, and the use of several score variants assists both
with future efforts to implement such scores in practice,
and with comparisons across populations. A number of
weaknesses should also be highlighted. Our approach is
slightly different from the original approach used by
Fried et al. [1], which could have affected the prevalence
of frailty that we found. However, the prevalence of
frailty was similar across a range of scores utilising
different components, including components used as an
alternative to the exhaustion component of frailty, which
we were unable to measure in the same way as Fried et
al. in our cohort. Our data are derived from a research-
based cohort study, not from clinical practice, and it re-
mains to be seen how easy it is to implement these
phenotypic scores in clinical practice, particularly in en-
vironments with constrained resources and few trained
staff. Those in the youngest age group (40–49 year olds)
are underrepresented in the HAALSI population in
comparison to the whole HDSS population; a significant
number of people in this age group are in work, often
migrate for work, and hence fall outside the residency
inclusion criteria that HAALSI employed in selecting
the study population. The lack of long-term follow up
data in the HAALSI project limits our ability to test how
frailty scores predict onset of ADL limitation, though
planned HAALSI follow-up surveys will allow for these
analyses in future. Whilst the ability of frailty scores to
predict hospitalisation and the need for institutional care
is an important consideration in high-income countries,
many older people in our study area do not have access
to, or choose not to access, hospital services. Similarly,
institutional care in our study area is extremely limited
and this is thus a less relevant endpoint in this
population.
How might phenotypic frailty scores be useful for future
care and research? Firstly, the ability to measure frailty
allows this to be used as a covariate in future analyses,
particularly those examining the relationship between
morbidity and outcomes. Secondly, the ability to identify
frailty and pre-frailty will allow research on the determi-
nants and consequences of frailty in this, and other sub-
Saharan African populations. Ultimately identification of
risk factors for frailty will permit the development of suc-
cessful prevention strategies, and the ability to identify
pre-frailty will potentially provide a window of opportun-
ity for interventions to prevent progression to frailty.
Within clinical practice, an easy to use frailty score will
allow identification of those at risk of adverse health and
functional outcomes, allowing planning of future health
and social care needs at a population level.
Conclusion
We have shown that phenotypic frailty scores can be
derived in this older South African population, and that
the components of such scores can be varied, albeit with
some variation in measured prevalence of frailty. We
have also demonstrated evidence of validity – frailty
scores were associated with worse health, wellbeing and
earlier death. Such scores will help to target interventions
to prevent and treat frailty at an individual or community
level – particularly comprehensive geriatric assessment,
but also pleiotropic interventions (e.g. exercise and nutri-
tion interventions) to delay the onset of adverse outcomes
in older people. Whilst such interventions still require
development and testing in sub-Saharan African popula-
tions, identification of those more likely to benefit is an
important first step in addressing this issue, which will
only increase in importance in the coming years.
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